Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Ltd

₹ 38.7 -0.74%
19 Apr - close price
About

Incorporated in 1992, Emmessar Biotech & Nutrition Ltd is in the business of Healthcare, Fine Chemicals and Renting of Immovable property[1]

Key Points

Business Overview:[1]
EBNL is a global healthcare company that manufactures and markets healthcare & nutritional products. It fuses various concepts & principles (both ancient & modern) from Biophysics, Biochemistry, Biotechnology and the Indian system of medicine AYUSH (Ayurveda + Yoga + Unani + Siddha + Homeopathy) to create products. This integration resulted in technology called VedaCeuticals which forms the foundation of all products of EBNL

  • Market Cap 19.3 Cr.
  • Current Price 38.7
  • High / Low 47.7 / 21.1
  • Stock P/E 33.3
  • Book Value 13.8
  • Dividend Yield 0.00 %
  • ROCE 15.0 %
  • ROE 7.79 %
  • Face Value 10.0

Pros

  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -4.29% over past five years.
  • Earnings include an other income of Rs.1.94 Cr.
  • Working capital days have increased from 53.9 days to 143 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
1.11 4.52 0.02 0.04 0.16 0.15 0.21 0.07 0.43 0.32 0.07 0.08 0.33
1.18 3.54 0.30 0.27 0.38 0.33 0.36 0.27 0.60 0.48 0.35 0.30 0.54
Operating Profit -0.07 0.98 -0.28 -0.23 -0.22 -0.18 -0.15 -0.20 -0.17 -0.16 -0.28 -0.22 -0.21
OPM % -6.31% 21.68% -1,400.00% -575.00% -137.50% -120.00% -71.43% -285.71% -39.53% -50.00% -400.00% -275.00% -63.64%
0.54 0.36 0.38 0.43 0.41 0.71 0.44 0.43 0.44 0.42 0.46 0.53 0.53
Interest -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Depreciation 0.01 0.01 0.01 0.02 0.02 0.04 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Profit before tax 0.46 1.33 0.09 0.18 0.17 0.49 0.27 0.21 0.25 0.24 0.16 0.29 0.30
Tax % -0.00% 60.90% -0.00% -0.00% -0.00% 91.84% 25.93% 33.33% 108.00% 20.83% 68.75% 31.03% 56.67%
0.45 0.52 0.09 0.18 0.17 0.03 0.20 0.13 -0.02 0.20 0.05 0.20 0.13
EPS in Rs 0.90 1.04 0.18 0.36 0.34 0.06 0.40 0.26 -0.04 0.40 0.10 0.40 0.26
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
3.20 0.58 1.37 2.19 1.98 2.61 1.27 0.63 3.40 6.99 0.36 1.02 0.80
3.23 0.77 1.43 2.34 2.66 2.38 1.67 1.27 3.81 6.15 1.26 1.71 1.67
Operating Profit -0.03 -0.19 -0.06 -0.15 -0.68 0.23 -0.40 -0.64 -0.41 0.84 -0.90 -0.69 -0.87
OPM % -0.94% -32.76% -4.38% -6.85% -34.34% 8.81% -31.50% -101.59% -12.06% 12.02% -250.00% -67.65% -108.75%
0.07 0.08 0.09 0.06 0.03 0.98 1.25 1.01 1.21 1.47 1.92 1.75 1.94
Interest -0.00 -0.00 -0.00 -0.00 -0.00 0.01 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 0.00
Depreciation 0.07 0.07 0.20 0.07 0.03 0.01 0.05 0.08 0.06 0.06 0.09 0.09 0.08
Profit before tax -0.03 -0.18 -0.17 -0.16 -0.68 1.19 0.80 0.29 0.74 2.25 0.93 0.97 0.99
Tax % -0.00% -0.00% -82.35% 25.00% 30.88% -0.00% -15.00% -82.76% -2.70% 36.00% 48.39% 47.42%
-0.03 -0.18 -0.31 -0.12 -0.47 1.19 0.91 0.53 0.75 1.45 0.48 0.50 0.58
EPS in Rs -0.06 -0.36 -0.62 -0.24 -0.94 2.38 1.82 1.06 1.50 2.90 0.96 1.00 1.16
Dividend Payout % -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00%
Compounded Sales Growth
10 Years: 6%
5 Years: -4%
3 Years: -33%
TTM: -7%
Compounded Profit Growth
10 Years: 17%
5 Years: -11%
3 Years: -20%
TTM: 71%
Stock Price CAGR
10 Years: 27%
5 Years: 15%
3 Years: 31%
1 Year: 53%
Return on Equity
10 Years: 17%
5 Years: 17%
3 Years: 14%
Last Year: 8%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00
Reserves -2.86 -3.04 -3.42 -3.62 -4.09 -2.91 -2.01 -1.49 -0.73 0.70 1.17 1.67 1.92
-0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 0.07 -0.00 -0.00 -0.00 0.08 -0.00
2.83 2.97 0.65 1.03 1.36 1.13 0.92 1.59 1.86 2.11 1.04 1.19 1.36
Total Liabilities 4.97 4.93 2.23 2.41 2.27 3.22 3.91 5.17 6.13 7.81 7.21 7.94 8.28
1.90 1.84 1.58 1.42 0.73 0.72 2.25 1.99 1.91 1.86 2.07 2.00 1.96
CWIP -0.00 -0.00 -0.00 -0.00 -0.00 0.80 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Investments -0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
3.07 3.08 0.64 0.98 1.53 1.69 1.65 3.17 4.21 5.94 5.13 5.93 6.31
Total Assets 4.97 4.93 2.23 2.41 2.27 3.22 3.91 5.17 6.13 7.81 7.21 7.94 8.28

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-0.01 -0.02 -0.00 -0.01 0.75 0.74 0.39 1.03 0.47 2.27 0.38
-0.00 -0.01 -0.00 -0.00 -0.74 -0.69 -0.37 -1.06 0.01 -2.61 -0.55
-0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Net Cash Flow -0.01 -0.03 -0.00 -0.01 0.01 0.05 0.01 -0.03 0.48 -0.34 -0.17

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 303.41 1,686.55 45.29 6.67 66.36 5.59 8.62 23.17 3.22 141.51 10.14 3.58
Inventory Days 25.08 529.25 267.67 335.80 136.88 121.67 52.14 2,049.62 272.56 7.24 196.54 127.75
Days Payable 374.75 5,146.50 121.67 150.87 76.04 76.04 5.79 1,628.46 189.61 51.70 56.15 -0.00
Cash Conversion Cycle -46.27 -2,930.70 191.29 191.60 127.20 51.22 54.97 444.33 86.18 97.05 150.52 131.33
Working Capital Days 21.67 37.76 29.31 38.33 22.12 85.31 175.31 498.25 30.06 79.37 -60.83 143.14
ROCE % -1.39% -8.78% -9.60% -10.81% -39.30% 80.00% 31.50% 17.66% 25.48% 45.14% 15.67% 15.02%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
58.50% 58.50% 58.50% 58.50% 58.20% 58.20% 58.53% 59.08% 59.33% 59.53% 59.53% 59.53%
0.20% 0.20% 0.20% 0.20% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19%
41.31% 41.31% 41.31% 41.31% 41.61% 41.61% 41.27% 40.73% 40.46% 40.27% 40.28% 40.26%
No. of Shareholders 6,3116,5526,5526,9996,9706,9757,0246,9336,8746,8226,8447,146

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents